Explore Our Network

Explore MTEC's network of innovators, investors, and research organizations—along with patents and funding opportunities—advancing medical technologies for military and civilian health.

Showing 11 Patents
Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNA

05-12-2017 • US-9833468-B2

KOLE, RYSZARD • COLLINS, FRANCIS S. • ERDOS, MICHAEL R. • CAO, KAN

University of Maryland Baltimore • Progeria Research Foundation Inc • Sarepta Therapeutics Inc • US Department of Health and Human Services

Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNA

03-05-2016 • US-9326992-B2

KOLE, RYSZARD • COLLINS, FRANCIS S. • ERDOS, MICHAEL R. • CAO, KAN

University of Maryland Baltimore • Progeria Research Foundation Inc • Sarepta Therapeutics Inc • US Department of Health and Human Services

Antisense antiviral compounds and methods for treating a filovirus infection

01-05-2012 • US-8168604-B2

STEIN, DAVID A. • IVERSEN, PATRICK L. • BAVARI, SINA • WELLER, DWIGHT D.

Sarepta Therapeutics Inc • US Army Medical Research and Development Command

Antisense antiviral compounds and methods for treating a filovirus infection

04-10-2011 • US-8030292-B2

STEIN, DAVID A. • IVERSEN, PATRICK L. • BAVARI, SINA • WELLER, DWIGHT D.

Sarepta Therapeutics Inc • US Army Medical Research and Development Command

Antisense antiviral compounds and methods for treating a filovirus infection

04-10-2011 • US-8030291-B2

STEIN, DAVID A. • IVERSEN, PATRICK L. • BAVARI, SINA • WELLER, DWIGHT D.

Sarepta Therapeutics Inc • US Army Medical Research and Development Command

Compounds are substantially uncharged morpholino oligonucleotides having a sequence of 12-40 subunits, including at least 12 subunits having a targeting sequence that is complementary to a region associated with viral RNA sequences within a 19 nucleotide region of the 5'-terminal regions of the viral RNA

01-09-2009 • US-7582615-B2

NEUMAN, BENJAMIN • STEIN, DAVID A. • BUCHMEIER, MICHAEL • IVERSEN, PATRICK L.

Scripps Research Institute • Sarepta Therapeutics Inc • US Department of Health and Human Services

Antisense antiviral compounds and methods for treating a filovirus infection

28-04-2009 • US-7524829-B2

STEIN, DAVID A. • IVERSEN, PATRICK L. • BAVARI, SINA

Sarepta Therapeutics Inc • US Army Medical Research and Development Command

Antisense antiviral compounds and methods for treating a filovirus infection

24-03-2009 • US-7507196-B2

STEIN, DAVID A. • IVERSEN, PATRICK L. • BAVARI, SINA • WELLER, DWIGHT D.

Sarepta Therapeutics Inc • United States Department of the Army • US Army Medical Research and Development Command

Oligonucleotide analogues targeting human LMNA

31-10-2023 • US-11802283-B2

ERDOS, MICHAEL R. • COLLINS, FRANCIS S. • CAO, KAN • KOLE, RYSZARD • BESTWICK, RICHARD KEITH • GORDON, LESLIE B.

Progeria Research Foundation • University of Maryland Baltimore • Progeria Research Foundation Inc • Sarepta Therapeutics Inc • US Department of Health and Human Services

Oligonucleotide analogues targeting human LMNA

03-11-2020 • US-10822608-B2

ERDOS, MICHAEL R. • COLLINS, FRANCIS S. • CAO, KAN • KOLE, RYSZARD • BESTWICK, RICHARD KEITH • GORDON, LESLIE B.

Progeria Research Foundation • University of Maryland Baltimore • Progeria Research Foundation Inc • Sarepta Therapeutics Inc • University of Maryland College Park • US Department of Health and Human Services

Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNA

03-09-2019 • US-10398721-B2

KOLE, RYSZARD • COLLINS, FRANCIS S. • ERDOS, MICHAEL R. • CAO, KAN • GORDON, LESLIE B.

University of Maryland Baltimore • Progeria Research Foundation Inc • Sarepta Therapeutics Inc • US Department of Health and Human Services

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.